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Abstract 
Review on t(6;12)(q21;p13), with data on the genes 
involved 
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Clinics and pathology 
Disease 
Translocation t(6;12)(q21;p13) is a rare abnormality, 
it occurs in both myeloid and lymphoid disorders 
including AML, ALL, and  
NHL.  
Acute lymphoblastic leukemia (ALL) was 
diagnosed in 6 pediatric patients, 4 of them were 
with early pre-B ALL (Raimondi et al., 1997; 
Hayashi et al., 1990), one patient with T-ALL 
(Kaneko et al., 1989).  
Acute myeloid leukemia (AML): there were 2 adult 
patients (Hosoya et al., 2005; Campbell et al., 1994). 
Small lymphocytic lymphoma was diagnosed in 1 
patient (Bloomfield et al., 1983). 
Epidemiology 
The t(6;12)(q21;p13) is a rare reciprocal 
translocation. Male predominance (Male : Female 
3,5 : 1).  
#  
Age, 
gender  
Diseasenbsp;  Karyotype  Author  
1  7, M  Early pre-B ALL  48,XY,t(6;12)(q21;p13),+16,+add(19)(p13)  Raimondi et al, 1997 
2  5,5, M  Early pre-B ALL  
46,XY,inv(12)(p13q22),add(21)(q22)/46,idem,t(6;12)(q21;p13)/46,XY,t(6;1
2),inv(12)   
Raimondi et al, 1997 
3  ?, M  ALL  46,XY,t(6;12)(q21;pl3)/46,XY  Katz et al, 1991 
4  ?, M  Early pre-B ALL  
48,XY.+16,+der(19)t(19;?)(p13;?),t(6:12)(q21;p13)/48XY,+16,+der(19),d 
e1(12)(p12),t(6;12)   
Hayashi et al., 1990 
5  ?, M  Early pre-B ALL  
46,XY,inv(12)(p13q22).-
21,+der(21)t(21;?)(q22;?)/46,XY,t(6;12)(q21:p13),inv(12),-
21,+der(21)/46,XY,t(6;12),inv(12)   
Hayashi et al., 1990 
6  10, F  T-cell ALL  46,XX,t(6;12)(q21;p13),t(7;14)(p15;q32)  Kaneko et al., 1989 
7  69, M  
Small Lymphocytic 
Lymphoma   
43-44,XY,-4,-7,-9,-11,-13,-
17,t(1;14)(p32;q32),t(6;12)(q21;p13),+der(7)t(7;?)(p22;?)+der(13)t(13;?)(q3
4;?),+der(17)t(17;17)(p13;?),+20   
Bloomfield 1983 
8  69, F  AML  46,XX,t(6;12)(q21;p13)  Hosoya et al., 2005 
9  55, M  
AML with 
maturation  
(FAB type M2)  
54,XY,t(6;12)(q21;p13),+8,+9,+10,+11,+13,+14,add(17)(p11),+20,+del(20)(
q11),+21   
Campbell et al., 1994 
Table 1. Reported cases with t(6;12)(q21;p13). 
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Prognosis 
Survival in ALL and AML patients was 40, 106+ and 
5 months respectively (Raimondi et al, 1997; Hosoya 
et al, 2005). 
Cytogenetics 
Additional anomalies 
Sole abnormality in 2 patients (1 ALL, 1 AML). 
Additional chromosome anomalies were observed in 
6/8 patients.   
In early pre B-ALL t(6;12)(q21;p13) was associated 
in combination with extra chromosome 16 in 2 
patients, and a complex karyotype in 2 cases 
(Hayashi et al., 1990; Raimondi et al., 1997). In 
small lymphocytic lymphoma, t(6;12)(q21;p13) is 
part of a complex karyotype. 
Genes involved and 
proteins 
ETV6 (ets variant 6) 
Location 12p13.2 
Protein 
ETV6 encodes an ETS family transcription factor. 
ETV6 protein contains two functional domains: a N-
terminal pointed (PNT) domain that is involved in 
protein-protein interactions with other proteins, and 
a C-terminal DNA-binding domain.  
Gene knockout studies suggest that it is required for 
hematopoiesis and maintenance of the developing 
vascular network.  
ETV6 is known to be involved in a large number of 
chromosomal abnormalities associated with 
leukemia and inborn fibrosarcoma. 
FRK (Fyn-related Src family tyrosine 
kinase) 
Location 6q22.1 
Protein 
FRK belongs to a family of SRC kinases. SRC is the 
prototype for a family of genes that encode non-
receptor tyrosine kinases implicated in a variety of 
cellular processes. The wild type FRK is expressed 
primarily in epithelial tissues, but also weakly in the 
various hematopoietic cell lines. However, its 
functions or downstream signaling pathways remain 
largely unknown, especially in hematopoietic 
systems. The only known candidate endogenous 
downstream component of FRK is the SH2-domain 
adaptor protein SHB (Hosoya et al., 2005). 
Result of the chromosomal 
anomaly 
Hybrid gene 
In the resultant ETV6/FRK fusion protein, the entire 
PNT oligomerization domain of ETV6 and the 
kinase domain of FRK are fused in frame. 
Fusion protein 
Oncogenesis 
It has been shown that ETV6/FRK is an oncoprotein 
with dual functions: deregulated tyrosine kinase 
activity and a dominant-negative modulation of 
transcriptional repression by ETV6. Because wild-
type ETV6 appears to have tumor-suppressive 
activity, its suppression by ETV6/ FRK also could 
contribute to oncogenesis (Hosoya et al., 2005). 
 
 
Figure 1. Schematic representation of wild-type ETV6, FRK, and the fusion transcript ETV6/FRK. The 
breakpoints are indicated by vertical arrows. 
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